Document is current
Any future updates will be listed below
-
Authors
van de Donk, Pim P https://orcid.org/0000-0002-0003-525X
Oosting, Sjoukje F
Knapen, Daan G
van der Wekken, Anthonie J
Brouwers, Adrienne H
Lub-de Hooge, Marjolijn N https://orcid.org/0000-0002-5390-2791
de Groot, Derk-Jan A
de Vries, Elisabeth GE
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03313323 at ClinicalTrials.govnct04566978 at ClinicalTrials.govDocuments that mention this clinical trial
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
nct04706715 at ClinicalTrials.govDocuments that mention this clinical trial
ImmunoPET imaging of LAG-3 expression in tumor microenvironment with <sup>68</sup>Ga-labelled cyclic peptides tracers: from bench to bedside
https://doi.org/10.1136/jitc-2024-009153
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
nct03780725 at ClinicalTrials.govDocuments that mention this clinical trial
ImmunoPET imaging of LAG-3 expression in tumor microenvironment with <sup>68</sup>Ga-labelled cyclic peptides tracers: from bench to bedside
https://doi.org/10.1136/jitc-2024-009153
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
nct04029181 at ClinicalTrials.govDocuments that mention this clinical trial
ImmunoPET imaging of LAG-3 expression in tumor microenvironment with <sup>68</sup>Ga-labelled cyclic peptides tracers: from bench to bedside
https://doi.org/10.1136/jitc-2024-009153
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
nct05126927 at ClinicalTrials.govDocuments that mention this clinical trial
Development of <sup>89</sup>Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration
https://doi.org/10.1136/jitc-2022-004877
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
nct04169321 at ClinicalTrials.govDocuments that mention this clinical trial
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
nct04721756 at ClinicalTrials.govDocuments that mention this clinical trial
Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity
https://doi.org/10.1136/jitc-2024-011009
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0
https://doi.org/10.1136/jitc-2023-006947
nct05000372 at ClinicalTrials.govDocuments that mention this clinical trial
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
Documents that mention this clinical trial
Molecular imaging to support cancer immunotherapy
https://doi.org/10.1136/jitc-2022-004949
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (POINTING (number 10034))
- License Information
